Switch to MMF beneficial in liver transplant recipients?

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1277, 2001-01, pp. : 14-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Brentuximab vedotin: Various toxicities (first reports except for pneumonia) in stem cell transplant recipients?: 3 case reports

Reactions Weekly, Vol. 1, Iss. 1410, 2012-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Swine flu vaccine ready soon, but are the recipients?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 586, 2009-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Clopidogrel not enough for some coronary stent recipients?

Inpharma, Vol. 1, Iss. 1576, 2007-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

MMF plus valaciclovir or aciclovir: no relevant interactions?

Inpharma, Vol. 1, Iss. 1449, 2004-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Immunosuppression in Elderly Renal Transplant Recipients: Are Current Regimens Too Aggressive?

By Meier-Kriesche H-U. Kaplan B.

Drugs & Aging, Vol. 18, Iss. 10, 2001-10 ,pp. : 751-759

Adis International

Access to resources Recommend Favorite